(Q39849123)

English

Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patients (English)

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Pseudomonas aeruginosa

0 references

1 reference

based on heuristic

inferred from title

author name string

Yu VL

1

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Zuravleff JJ

2

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Peacock JE

3

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

DeHertogh D

4

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Tashjian L

5

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

language of work or name

0 references

publication date

1 October 1984

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

26

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

4

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

575-577

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Addition of rifampin to ticarcillin-tobramycin combination for the treatment of Pseudomonas aeruginosa infections: assessment in a neutropenic mouse model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179966

15 June 2018

Pseudomonas bacteremia: can antibiotic therapy improve survival?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179966

15 June 2018

Treatment of patients with pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6517547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/6517547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6517547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/6517547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.26.4.575

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39849123&oldid=2091464001"